Differentiation of B Cells and the Clonal Abortion Theory

  • G. J. V. Nossal
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 114)

Abstract

During the early years of research on immunological tolerance (1), it was generally believed that induction of the phenomenon could only be achieved in embryonic or very young animals, implying a special susceptibility of immature lymphoid cells. A plausible mechanism for tolerance emerged in 1957, when Burnet (2) postulated his clonal selection theory, and ascribed tolerance to a deletion of clones through contact between immature lymphocytes with their corresponding antigen. This straightforward view of the problem received a number of challenges during the 1960’s. A watershed was the discovery by Dresser (3) that small amounts of de-aggregated proteins could induce tolerance in adult mice. A further complication was the discovery of the helper function of T lymphocytes and the demonstration that, in some tolerance models, tolerance was confined to the T lymphocyte compartment (4). Then, when the important role of suppressor T cells in antibody formation and immunological tolerance became clear (5,6), the idea of clonal deletion as a general explanation of tolerance lost favour in many quarters.

Keywords

Tolerance Induction Immunological Tolerance Newborn Cell Tolerance Model Special Susceptibility 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Medawar, P.B. Harvey Lectures 52 (1958) 144.Google Scholar
  2. 2.
    Burnet, F.M. Aust. J. Sci. 20 (1957) 67.Google Scholar
  3. 3.
    Dresser, D.W. Immunol. 4 (1961) 13.Google Scholar
  4. 4.
    Weigle, W.O., Chiller, J.M., Habicht, G.S. Transplant. Rev. 8 (1972) 3.PubMedGoogle Scholar
  5. 5.
    Gershon, R.K., Kondo, K. Immunol. 21 (1971) 903.Google Scholar
  6. 6.
    McCullogh, P. Transplant. Rev. 12 (1972) 180.Google Scholar
  7. 7.
    Nossal, G.J.V., Shortman, K., Howard, M., Pike, B.L. Immunol. Rev. 37 (1977) 188.CrossRefGoogle Scholar
  8. 8.
    Nossal, G.J.V., Pike, B.L., Teale, J.M., Layton, J.E., Kay, T.W., Battye, F.L. Immunol. Rev. (1978) in press.Google Scholar
  9. 9.
    Nossal, G.J.V., Pike, B.L. In: Immunological Aspects of Neoplasia. E.M. Hersh, M. Schlamowitz (eds). Baltimore, Williams and Wilkins (1975b) p.87.Google Scholar
  10. 10.
    Nossal, G.J.V., Pike, B.L. J. exp. Med. 141 (1975) 904.PubMedGoogle Scholar
  11. 11.
    Stocker, J.W. Immunol. 32 (1977) 283.Google Scholar
  12. 12.
    Nossal, G.J.V., Pike, B.L. J. Immunol. 120(1) (1978) 145.PubMedGoogle Scholar
  13. 13.
    Metealf, E.S., Klinman, N.R. J. exp. Med. 143 (1976) 1327.CrossRefGoogle Scholar
  14. 14.
    Metealf, E.S., Klinman, N.R. J. Immunol. 118 (1977) 2111.Google Scholar
  15. 15.
    Nossal, G.J.V., Pike, B.L. J. exp. Med. (1978) November.Google Scholar
  16. 16.
    Haas, W., Layton, J.E. J. exp. Med. 141 (1975) 1004.PubMedCrossRefGoogle Scholar
  17. 17.
    Cambier, J.C., Vitetta, E.S., Uhr, J.W., Kettman, J.R. J. exp. Med. 145 (1977b) 778.CrossRefGoogle Scholar
  18. 18.
    Metealf, D., Nossal, G.J.V., Warner, N.L., Miller, J.F.A.P., Mandel, T.E., Layton, J.E., Gutman, G.A. J. exp. Med. 142 (1975) 1534.CrossRefGoogle Scholar
  19. 19.
    Kearney, J.F., Klein, J., Bockman, D.E., Cooper, M.D., Lawton, A.R. J. Immunol. 120 (1978) 158.PubMedGoogle Scholar
  20. 20.
    Schrader, J.W. Europ. J. Immunol. 4 (1974) 20.CrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1979

Authors and Affiliations

  • G. J. V. Nossal
    • 1
  1. 1.The Walter and Eliza Hall Institute of Medical Research Post OfficeRoyal Melbourne HospitalAustralia

Personalised recommendations